← SynDRA
POMAGLUMETAD METHIONIL ANHYDROUS
SynDRA canonical compound SYN0033400 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | GRM2 | GRM3 |
|---|
| Mechanism of action | glutamate receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- GRM2 AGONIST
- Metabotropic glutamate receptor 2 agonist
- GRM3 AGONIST
- Metabotropic glutamate receptor 3 agonist
- glutamate receptor agonist
Cross-references
Synonyms
- LY2140023
- LY-2140023
- Pomaglumetad Methionil
- UNII-3V85EZ3KFQ
- Pomaglumetad methionil free base
- 3V85EZ3KFQ
- Pomaglumetad methionil [USAN:INN]
- Pomaglumetad methionil (anhydrous)
- Pomaglumetad methionil (INN)
- POMAGLUMETAD METHIONIL [INN]
- orb1709224
- SCHEMBL1101575
- GLXC-20647
- AKOS040733641
- POMAGLUMETAD METHIONIL [WHO-DD]
- DA-56979
- HY-14554
- CS-0003440
- D10896
- T11907
- pomaglumetad methionil
- Pomaglumetad metionilo
- Pomaglumetad methionil
- UNII-WE665JB15R
- pomaglumetad methionil hydrate
- AKOS040735205
- pomaglumetad methionil monohydrate
- pomaglumetad metionilo
- LY-2140023 MONOHYDRATE
- LY-2140023 Monohydrate
- DTXCID30135435
- CS-0024754
- SCHEMBL1100180
- LY2140023 MONOHYDRATE
- WE665JB15R
- pomaglumetadum methionilum
- LY2140023 Monohydrate
- T12520
Look up POMAGLUMETAD METHIONIL ANHYDROUS in the interactive SynDRA portal →